CPHRF News and Press, Companhia Siderurgica Paulista Nova Cosipa From 05/05/21

Cipher Pharmaceuticals Schedules Q1 2021 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON , May 5, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (" Cipher " or "the Company ") today announced it will release its Q1 2021 ...

Cipher Pharmaceuticals ([[CPHRF]] -4.0%) announces that it has received approval from the Toronto Stock Exchange to amend its normal course issuer bid ((NCIB)) in order to enter into an automatic repurchase plan with its designated broker.The automatic repurchase plan enables Cipher to p...

Cipher Pharmaceuticals, Inc. (CPHRF) Q4 2020 Results Conference Call March 19, 2021 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Scott Langille - Chief Financial Officer Conference Call Participants Doug Loe - Leede Jones Gable Presentation Operator Good mornin...

Cipher Pharmaceuticals (CPHRF): Q4 Non-GAAP EPS of $0.19; GAAP EPS of $0.00 misses by $0.07.Revenue of $6.1M (+3.4% Y/Y) beats by $1.36M.Press Release For further details see: Cipher Pharmaceuticals EPS misses by $0.07, beats on revenue

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results Canada NewsWire Adjusted EBITDA increases 9% to $13.7 million and EPS increases 60% to $0.16 ( CDN$0.21 1 ) for the full year OAKVILLE, ...

Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON , March 10, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced it will release its Q4 2...

Cipher Pharmaceuticals Receives Arbitration Award on Trulance® Canada NewsWire OAKVILLE, ON , Jan. 15, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced it has received an arbitration award in the previously...

Cipher Pharmaceuticals, Inc. (CPHRF) Q3 2020 Earnings Conference Call November 13, 2020 8:30 AM ET Company Participants Craig Mull – Interim Chief Executive Officer Scott Langille – Chief Financial Officer Conference Call Participants Prasath Pandurangan – Bloom Burton Do...

Cipher Pharmaceuticals (CPHRF): Q3 GAAP EPS of $0.06 beats by $0.02.Revenue of $4.9M (-15.5% Y/Y) beats by $0.94M.Press Release For further details see: Cipher Pharmaceuticals EPS beats by $0.02, beats on revenue

Cipher Pharmaceuticals Reports Third Quarter 2020 Financial Results Canada NewsWire OAKVILLE, ON, Nov. 12, 2020 Revenue Increases Sequentially to $4.9 million EBITDA 2 was $2.7 million or 55% of net revenue OAKVILLE, ON , Nov. 12, 2020...